三祥新材(603663.SH):前三季度淨利預增50.65%-66.62%
格隆匯10月12日丨三祥新材(603663.SH)公佈2021年前三季度業績預增公吿,公司預計2021年前三季度歸屬於上市公司股東的淨利潤約6600.00萬元至7300.00萬元,預計同比預計將增加2214.84萬元到2918.84萬元,同比增長50.65%到66.62%。
預計2021年前三季度公司歸屬於上市公司股東的扣除非經常性損益的淨利潤預計約為6300.00萬元至7000.00萬元,預計同比增加2289.75萬元到2989.75萬元,同比增長57.10%到74.55%。
公司本次業績預增的主要原因為:公司鋯系產品市場逐漸回暖,公司主營產品量價齊升所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.